Page last updated: 2024-12-06

1-(2-naphthyl)ethanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

1-(2-Naphthyl)ethanol is a chiral organic compound with the following structure:

* **Structure:** It consists of a naphthalene ring (two fused benzene rings) with a hydroxyl group (-OH) attached to the first carbon atom of the naphthalene ring and an ethyl group (-CH2CH3) attached to the second carbon atom.

**Why is 1-(2-Naphthyl)ethanol important for research?**

1-(2-Naphthyl)ethanol is not commonly known for being directly important in research. It's likely a compound that researchers may encounter in synthetic chemistry or as a potential intermediate in organic synthesis. However, its importance stems from several factors:

* **Chiral Building Block:** Due to its chiral nature (having a stereogenic center), it can be used as a building block in the synthesis of other chiral molecules. This is particularly relevant in the pharmaceutical industry, where enantiomers (mirror-image forms) of a drug can have different biological effects.
* **Stereochemistry Studies:** It could be used in studies related to understanding and controlling stereochemistry in chemical reactions. Researchers might use it to investigate the influence of chirality on reaction pathways and product formation.
* **Material Science:** It might have potential applications in the synthesis of functional materials with specific properties. For example, its naphthyl group might impart fluorescence or other optical properties to the resulting materials.

**To understand its specific importance, more context is needed:**

* **What specific research area are you interested in?**
* **What is the context of its use?** Is it a starting material, a product, or a reagent?
* **What are the specific properties of 1-(2-Naphthyl)ethanol that are of interest?**

Providing more information about your inquiry would allow for a more specific and relevant response.

Cross-References

ID SourceID
PubMed CID98243
SCHEMBL ID110360
MeSH IDM0356681

Synonyms (47)

Synonym
2-naphthalenemethanol, .alpha.-methyl-, ( )-
2-naphthalenemethanol, .alpha.-methyl-, (.+/-.)-
1-(2-naphthyl)ethanol
.alpha.-methyl-2-naphthalenemethanol
nsc92277
7228-47-9
nsc-92277
IDI1_031077
alpha-methyl-2-naphthalenemethanol, 98%
MAYBRIDGE4_000495
NCGC00177518-01
HMS1522G11
N0788
alpha-methyl-2-naphthalenemethanol
2-(1-hydroxyethyl)naphthalene
AKOS000248910
BRD-A66746621-001-01-3
1-naphthalen-2-ylethanol
FT-0639633
40295-80-5
1-(naphthalen-2-yl)ethan-1-ol
EN300-51954
A825040
alpha-methylnaphthalene-2-methanol
einecs 230-630-3
nsc 92277
FT-0605556
FT-0638712
1-(naphthalen-2-yl)ethanol
SCHEMBL110360
(+/-)-1-(2-naphthyl)ethanol
1-(naphthalene-2-yl)ethanol
2-(1'-hydroxyethyl)naphthalene
(rs)-1-(2-naphthyl)ethanol
2-naphthalenemethanol, .alpha.-methyl-
methyl 2-naphtylcarbinol
.beta.-naphthyl methyl carbinol
mfcd00004111
AS-14347
AMY41195
R10069
CS-0186229
SY289040
alpha -methyl-2-naphthalenemethanol
Z335245116
SY107397
SY107316
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's5 (55.56)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]